Transdermal Drug Delivery System Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type (Transdermal Patches and Transdermal Semisolids); Application (Cardiovascular Diseases, Central Nervous System Disorders, Pain Management, Hormonal Applications and Others); End User (Hospitals & Clinics, Home Care Settings and Others); and Geography

Publication Month: May 2020 | Report Code: TIPRE00002894 | No. of Pages: 228 | Category: Medical Device | Status: Published

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The transdermal drug delivery system market was valued at US$ 6,063.85 million in 2019 and is projected to reach US$  8,415.04 million 2027; it is expected to grow at a CAGR of 4.3% from 2020 to 2027.

 

Transdermal Drug Delivery System (TDDS) is described as a self-contained or discrete dosage form known as patches or semisolid forms that are applied to the intact skin. There are different types of semisolid forms, such as, creams, ointments, gels, and sprays. Dosage forms are designed to deliver a therapeutically effective amount of drug across a patient’s skin. The transdermal drug delivery system market is expected to witness a huge growth due to increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices, and high demand for self-administration of drugs. However, high cost involved in development of drug delivery systems along with drug failure and recalls of transdermal drug delivery systems are likely to restraint the growth of the market during the forecast years.

 

Lucrative Regions for Transdermal Drug Delivery System Market

Lucrative Regions for Transdermal Drug Delivery System Market

Get more information on this report :


 

Market Insights

Growing Demand for Non-Invasive Drug Delivery Devices

With the improvements in medical science and definite oral drug delivery technologies, the non-invasive mode of drug delivery system is now prepared to compete with traditional methods of injectable and painful routes of drug delivery. The non-invasive drug delivery systems include drug delivery via oral, topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and via alveolar membrane from inhaled medication. Transdermal delivery has a range of advantages compared to the oral route. In particular, it is used when there is a significant first-pass effect of the liver that can impulsively metabolize drugs. Transdermal delivery also has advantages over hypodermic injections, which are painful, create dangerous medical waste, and pose the risk of disease transmission by needle re-use, especially in developing countries. Additionally, transdermal systems are non-invasive and can be self-administered. Patient compliance has been found to be much higher when administrated by non-invasive routes due to decreased pain involved in drug delivery. Therefore, these techniques are considered a preferred mode of drug delivery, thereby driving the market growth in the review period.

 

Type-Based Insights

Based on type, the transdermal drug delivery system market is segmented into transdermal patches and transdermal semisolids. The transdermal patch segment is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and micro needle patches. The transdermal semisolids segment is further sub segmented into gels, ointments, and sprays. The transdermal patches segment held the larger share of the market in 2019, owing to the advantages such as better patient compliance, faster onset of action, and improved permeability and efficacy. Also, the transdermal patches segment is expected to register a higher CAGR in the market during the forecast period. Additionally, growing emphasis on implementation of inorganic strategies to elevate manufacturing capacity is also projected to drive the transdermal patches segment growth. For instance, in August 2019, Canoa Inc. announced its plan to acquire privately-held ProSolus Inc. to accelerate transdermal drug delivery product development. This strategic acquisition will consolidate company’s transdermal drug delivery products manufacturing capacity.

 

Global Transdermal Drug Delivery System Market, by Type – 2019 & 2027

Global Transdermal Drug Delivery System Market, by Type – 2019 & 2027

Get more information on this report :


 

Application-Based Insights

Based on application, the transdermal drug delivery system market is segmented into pain management, central nervous system disorders, hormonal applications, cardiovascular diseases, and other applications. The hormonal applications segment is further sub segmented into transdermal estrogen therapy and testosterone replacement. In 2019, the pain management segment accounted for the largest share of the global transdermal drug delivery system market owing to increasing number of transdermal drug delivery systems for the pain management. Also, pain management segment is estimated to register the highest CAGR in the market during the forecast period.

 

End User-Based Insights

Based on end user, the transdermal drug delivery system market is further segmented into hospitals and clinics, home care settings, and others. The hospitals and clinics segment held the largest share of the market in 2019, owing to increasing emphasis on adoption of transdermal drug delivery systems in clinics. Hospitals serve a significant role by providing extensive range of medical services to the patient population suffering from wide variety of diseases. This increased the adoption of drug delivery systems in hospitals and clinics.

 

Strategic Insights

Product launches and expansion strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the transdermal drug delivery system market adopted the strategy of product innovation to cater to changing customer demand across the world, which also permits the players to maintain their brand name globally.

 

Transdermal Drug Delivery System Market – By Type

  • Transdermal Patches
    • Matrix Patches
    • Microneedle Patches
    • Drug-In-Adhesive Patches
    • Reservoir Membrane Patches
  • Transdermal Semisolids
    • Sprays
    • Gels
    • Ointments

Transdermal Drug Delivery System Market – By Application

  • Cardiovascular Diseases
  • Central Nervous System Disorders
  • Pain Management
  • Hormonal Applications
    • Transdermal Estrogen Therapy
    • Testosterone Replacement Therapy
  • Other Applications

Transdermal Drug Delivery System Market – By End User

  • Hospitals and Clinics
  • Home Care Settings
  • Other End Users

Transdermal Drug Delivery System Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific(APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America (SAM)
    • Brazil
    • Argentina
    • Rest of SAM

 

Company Profiles

  • Novartis Ag
  • Johnson & Johnson Services, Inc.
  • Glaxosmithkline Plc.
  • Bayer Ag
  • Mylan N.V.
  • Boehringer Ingelheim International Gmbh
  • Hisamitsu Pharmaceutical Co.,Inc.
  • Luye Pharma Group
  • Purdue Pharma L.P.
  • Lavipharm

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Transdermal Drug Delivery System Market– By Type

1.3.2        Global Transdermal Drug Delivery System Market– By Application

1.3.3        Global Transdermal Drug Delivery System Market– By End User

1.3.4        Global Transdermal Drug Delivery System Market– By Geography

2.             Transdermal Drug Delivery System Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Transdermal Drug Delivery System – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America– PEST Analysis

4.2.2        Europe– PEST Analysis

4.2.3        Asia Pacific– PEST Analysis

4.2.4        Middle East & Africa

4.2.5        South and Central America

4.3       Expert Opinion

5.             Global Transdermal Drug Delivery System Market – Industry Dynamics

5.1       Market Drivers

5.1.1        Increasing Prevalence of Chronic Diseases

5.1.2        Growing Demand for Non-Invasive Drug Delivery Devices

5.1.3        High Demand for Self-Administration of Drugs

5.2       Market Restraints

5.2.1        High Cost Involved in Development of Drug Delivery Systems

5.2.2        Drug Failure and Recalls of Transdermal Drug Delivery Systems

5.3       Market Opportunities

5.3.1        Strategic Activities by the Manufacturers

5.4       Future Trends

5.4.1        Rise in Adoption of Third-Generation Delivery Systems

5.5       Impact Analysis

6.             Transdermal Drug Delivery System Market – Global Analysis

6.1       Global Transdermal Drug Delivery System Market Revenue Forecast And Analysis

6.2       Global Transdermal Drug Delivery System Market, By Geography - Forecast And Analysis

6.3       Market Positioning of Key Players

7.             Transdermal Drug Delivery System Market Analysis – By Type

7.1       Overview

7.2       Transdermal Drug Delivery System Market Revenue Share, by Type (2019 and 2027)

7.3       Transdermal Patch

7.3.1        Overview

7.3.2        Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

7.3.3        Drug-In-Adhesive Patches

7.3.3.1      Overview

7.3.3.2      Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

7.3.4        Matrix Patches

7.3.4.1      Overview

7.3.4.2      Matrix Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

7.3.5        Reservoir Membrane Patches

7.3.5.1      Overview

7.3.5.2      Reservoir Membrane Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

7.3.6        Microneedle Patches

7.3.6.1      Overview

7.3.6.2      Microneedle Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

7.4       Transdermal Semisolids

7.4.1        Overview

7.4.2        Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

7.4.3        Gel

7.4.3.1      Overview

7.4.3.2      Gel: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

7.4.4        Sprays

7.4.4.1      Overview

7.4.4.2      Spray: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

7.4.5        Ointments

7.4.5.1      Overview

7.4.5.2      Ointments: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

8.             Transdermal Drug Delivery System Market – By Application

8.1       Overview

8.2       Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)

8.3       Cardiovascular Diseases

8.3.1        Overview

8.3.2        Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

8.4       Central Nervous System Disorders

8.4.1        Overview

8.4.2        Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

8.5       Pain Management

8.5.1        Overview

8.5.2        Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

8.6       Hormonal Applications

8.6.1        Overview

8.6.2        Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

8.6.3        Hormonal Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

8.6.4        Transdermal Estrogen Therapy

8.6.4.1      Overview

8.6.4.2      Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

8.6.5        Testosterone Replacement

8.6.5.1      Overview

8.6.5.2      Testosterone Replacement: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

8.7       Other Applications

8.7.1        Overview

8.7.2        Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

8.7.3        Other Applications: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

9.             Transdermal Drug Delivery System Market – By End User

9.1       Overview

9.2       Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)

9.3       Hospitals and Clinics

9.3.1        Overview

9.3.2        Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

9.4       Home Care Settings

9.4.1        Overview

9.4.2        Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

9.5       Other End Users

9.5.1        Overview

9.5.2        Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

9.5.3        Other End Users: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

10.          Transdermal Drug Delivery System Market – Geographic Analysis

10.1    North America: Transdermal Drug Delivery System Market

10.1.1     Overview

10.1.2     North America: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.3     North America Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.3.1    North America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.3.2    North America Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.4     North America Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.4.1    North America Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.5     North America Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.6     North America: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)

10.1.7     US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1    US: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2    US Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.1.7.2.1    US Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.2.2    US Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.3    US Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.7.3.1    US Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4    US Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.8     Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1    Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2    Canada Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.2.1    Canada Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.2.2    Canada Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.3    Canada Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.8.3.1    Canada Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4    Canada Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.1.9     Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1    Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2    Mexico Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.1    Mexico Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.2.2    Mexico Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.3    Mexico Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.1.9.3.1    Mexico Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4    Mexico Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2    Europe: Transdermal Drug Delivery System Market

10.2.1     Overview

10.2.2     Europe: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027 (USD Million)

10.2.3     Europe Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.3.1    Europe Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.3.2    Europe Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.4     Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027  (USD Million)

10.2.4.1    Europe Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.5     Europe Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.6     Europe: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)

10.2.7     Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.1    Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.7.2    Germany Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.2.1    Germany Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.2.2    Germany Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.3    Germany Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.7.3.1    Germany Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.7.4    Germany Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.8     UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.1    UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.8.2    UK Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.2.1    UK Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.2.2    UK Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.3    UK Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.8.3.1    UK Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.8.4    UK Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.9     France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.1    France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.9.2    France Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.2.1    France Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.2.2    France Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.3    France Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.9.3.1    France Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.9.4    France Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.10   Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.1 Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.10.2 Spain Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.2.1 Spain Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.2.2 Spain Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.3 Spain Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.10.3.1 Spain Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.10.4 Spain Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.2.11   Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.1 Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.2.11.2 Italy Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.2.1 Italy Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.2.2 Italy Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.3 Italy Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.2.11.3.1 Italy Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.2.11.4 Italy Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3    Asia Pacific: Transdermal Drug Delivery Systems Market

10.3.1     Overview

10.3.2     Asia Pacific: Transdermal Drug Delivery Systems Market - Revenue and Forecast to 2027 (USD Million)

10.3.3     Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.3.4     Asia Pacific Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.5     Asia Pacific Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.6     Asia Pacific Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.7     Asia Pacific Hormonal Application Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.8     Asia Pacific Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.9     Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

10.3.10   China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.1 China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.10.2 China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.2.1 China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.2.2 China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.3.10.3 China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.10.3.1 China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.10.4 China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.11   Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.1 Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.11.2 Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.2.1 Japan Transdermal Patches Market, by Transdermal Patches – Revenue and Forecast to 2027 (USD Million)

10.3.11.2.2 Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

10.3.11.3 Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.11.3.1 Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.11.4 Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.12   India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.12.1 India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.12.2 India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.12.2.1 India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.12.2.2 India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.12.3 India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.12.3.1 India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.12.4 India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.3.13   South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.13.1 South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.13.2 South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.13.2.1 South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.13.2.2 South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.13.3 South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

10.3.13.3.1 South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.13.4 South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027  (USD Million)

10.3.14   Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.14.1 Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.3.14.2 Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.14.2.1 Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.14.2.2 Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.14.3 Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.3.14.3.1 Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.3.14.4 Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4    South and Central America: Transdermal Drug Delivery Systems Market

10.4.1     Overview

10.4.2     South and Central America: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.4.3     South and Central America Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.3.1    South and Central America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.3.2    South and Central America Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.4     South and Central America Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.4.4.1    South and Central America Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.5     South and Central America Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.6     South and Central America: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

10.4.7     Brazil: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.1    Brazil: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.4.7.2    Brazil Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.2.1    Brazil Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.2.2    Brazil Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.3    Brazil Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.4.7.3.1    Brazil Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.7.4    Brazil Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.4.8     Argentina: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.1    Argentina: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

10.4.8.2    Argentina Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.2.1    Argentina Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.2.2    Argentina Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.3    Argentina Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

10.4.8.3.1    Argentina Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.4.8.4    Argentina Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5    Middle East & Africa: Transdermal Drug Delivery System Market

10.5.1     Overview

10.5.2     Middle East &Africa: Transdermal Drug Delivery System Market - Revenue and Forecast to 2027  (US$ Million)

10.5.3     Middle East & Africa Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.3.1    Middle East & Africa Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.3.2    Middle East & Africa Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.4     Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.4.1    Middle East & Africa Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.5     Middle East & Africa Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.6     Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2018 & 2027 (%)

10.5.7     Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.1    Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.7.2    Saudi Arabia Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027  (USD Million)

10.5.7.2.1    Saudi Arabia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.2.2    Saudi Arabia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.3    Saudi Arabia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.7.3.1    Saudi Arabia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.7.4    Saudi Arabia Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.8     UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.1    UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.8.2    UAE Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.2.1    UAE Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.2.2    UAE Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.3    UAE Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.8.3.1    UAE Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.8.4    UAE Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

10.5.9     South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.9.1    South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

10.5.9.2    South Africa Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.9.2.1    South Africa Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.9.2.2    South Africa Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.9.3    South Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.5.9.3.1    South Africa Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

10.5.9.4    South Africa Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

11.          Impact Of COVID-19 Pandemic On Global Transdermal Drug Delivery System Market

11.1    North America: Impact assessment of COVID-19 Pandemic

11.2    Europe: Impact assessment of COVID-19 Pandemic

11.3    Asia-Pacific: Impact assessment of COVID-19 Pandemic

11.4    Rest of World: Impact assessment of COVID-19 Pandemic

12.          Transdermal Drug Delivery System Market – Industry Landscape

12.1    Overview

12.2    Growth Strategies Done by the Companies in the Market, (%)

12.3    Organic Developments

12.3.1     Overview

12.4    Inorganic Developments

12.4.1     Overview

13.          Transdermal Drug Delivery System Market –Company Profiles

13.1    Novartis AG

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    Johnson & Johnson Services, Inc.

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Bayer AG

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    MYLAN N.V.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Boehringer Ingelheim International GmbH

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    Hisamitsu Pharmaceutical Co ,Inc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Luye Pharma Group

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Purdue Pharma L.P.

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10 Lavipharm

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.          Appendix

14.1    About The Insight Partners

14.2    Word Index

 

LIST OF TABLES

Table 1.             North America Transdermal Drug Delivery System Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 2.             North America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             North America Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             North America Transdermal Drug Delivery System Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 5.             North America Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             North America Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 7.             US Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             US Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             US Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          US Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          US Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          US Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 13.          Canada Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Canada Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Canada Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 16.          Canada Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 17.          Canada Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 18.          Canada Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 19.          Mexico Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 20.          Mexico Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 21.          Mexico Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 22.          Mexico Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 23.          Mexico Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 24.          Mexico Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 25.          Europe Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26.          Europe Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 27.          Europe Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 28.          Europe Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 29.          Europe Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30.          Europe Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 31.          Germany Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32.          Germany Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 33.          Germany Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 34.          Germany Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 35.          Germany Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36.          Germany Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 37.          UK Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 38.          UK Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 39.          UK Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 40.          UK Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 41.          UK Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 42.          UK Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 43.          France Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44.          France Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 45.          France Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 46.          France Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 47.          France Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 48.          France Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 49.          Spain Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 50.          Spain Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 51.          Spain Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 52.          Spain Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 53.          Spain Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 54.          Spain Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 55.          Italy Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 56.          Italy Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 57.          Italy Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 58.          Italy Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 59.          Italy Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 60.          Italy Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 61.          Asia Pacific Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 62.          Asia Pacific Transdermal Patches Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 63.          Asia Pacific Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 64.          Asia Pacific Transdermal Drug Delivery Systems Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 65.          Asia Pacific Hormonal Application Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 66.          Asia Pacific Transdermal Drug Delivery Systems Market, by End User– Revenue and Forecast to 2027 (USD Million)

Table 67.          China Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 68.          China Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 69.          China Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 70.          China Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 71.          China Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 72.          China Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 73.          Japan Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 74.          Japan Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 75.          Japan Transdermal Semisolids Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 76.          Japan Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 77.          Japan Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 78.          Japan Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 79.          India Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 80.          India Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 81.          India Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 82.          India Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 83.          India Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 84.          India Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 85.          South Korea Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 86.          South Korea Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 87.          South Korea Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 88.          South Korea Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 89.          South Korea Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 90.          South Korea Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 91.          Australia Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 92.          Australia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 93.          Australia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 94.          Australia Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 95.          Australia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 96.          Australia Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 97.          South and Central America Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 98.          South and Central America Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 99.          South and Central America Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 100.       South and Central America Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 101.       South and Central America Hormonal Applications Market, by Type – Revenue and Forecast to 2027  (USD Million)

Table 102.       South and Central America Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 103.       Brazil Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 104.       Brazil Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 105.       Brazil Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 106.       Brazil Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 107.       Brazil Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 108.       Brazil Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 109.       Argentina Transdermal Drug Delivery Systems Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 110.       Argentina Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 111.       Argentina Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 112.       Argentina Transdermal Drug Delivery Systems Market, by Application – Revenue and Forecast to 2027  (USD Million)

Table 113.       Argentina Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 114.       Argentina Transdermal Drug Delivery Systems Market, by End User – Revenue and Forecast to 2027  (USD Million)

Table 115.       Middle East & Africa Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 116.       Middle East & Africa Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 117.       Middle East & Africa Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 118.       Middle East & Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 119.       Middle East & Africa Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 120.       Middle East & Africa Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 121.       Saudi Arabia Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 122.       Saudi Arabia Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 123.       Saudi Arabia Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 124.       Saudi Arabia Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 125.       Saudi Arabia Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 126.       Saudi Arabia Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 127.       UAE Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 128.       UAE Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 129.       UAE Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 130.       UAE Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 131.       UAE Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 132.       UAE Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 133.       South Africa Transdermal Drug Delivery System Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 134.       South Africa Transdermal Patches Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 135.       South Africa Transdermal Semisolids Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 136.       South Africa Transdermal Drug Delivery System Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 137.       South Africa Hormonal Applications Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 138.       South Africa Transdermal Drug Delivery System Market, by End User – Revenue and Forecast to 2027 (USD Million)

Table 139.       Organic Developments Done By Companies

Table 140.       Inorganic Developments Done By Companies

Table 141.       List of Abbreviation

 

LIST OF FIGURES

Figure 1.           Transdermal Drug Delivery System Market Segmentation

Figure 2.           Transdermal Drug Delivery System Market, By Region

Figure 3.           Global Transdermal Drug Delivery System Market Overview

Figure 4.           Transdermal Patches Segment Held Largest Share of Transdermal Drug Delivery System Market

Figure 5.           Asia-Pacific Region to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Transdermal Drug Delivery System Market, By Geography (US$ Million)

Figure 7.           Global Transdermal Drug Delivery System Market- Leading Country Markets (US$ Million)

Figure 8.           Global Transdermal Drug Delivery System Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia Pacific PEST Analysis

Figure 12.        Middle East & Africa PEST Analysis

Figure 13.        South and Central America PEST Analysis

Figure 14.        Global Transdermal Drug Delivery System Market – Revenue Forecast And Analysis – 2019- 2027

Figure 15.        Global Transdermal Drug Delivery System Market – By Geography Forecast and Analysis – 2019- 2027

Figure 16.        Market Positioning Of Key Players In Global Transdermal Drug Delivery System Market

Figure 17.        Transdermal Drug Delivery System Market Revenue Share, by Type (2019 and 2027)

Figure 18.        Transdermal Patch: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Drug-In-Adhesive Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

Figure 20.        Matrix Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Reservoir Membrane Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

Figure 22.        Microneedle Patches: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

Figure 23.        Transdermal Semisolids: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

Figure 24.        Gel: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Spray: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Ointments: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027 (US$ Million)

Figure 27.        Transdermal Drug Delivery System Market, by Application, 2019 and 2027 (%)

Figure 28.        Cardiovascular Diseases: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

Figure 29.        Central Nervous System Disorders: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

Figure 30.        Pain Management: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027  (US$ Million)

Figure 31.        Transdermal Estrogen Therapy: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

Figure 32.        Testosterone Replacement: Transdermal Drug Delivery System Market– Revenue and Forecast to 2027  (US$ Million)

Figure 33.        Transdermal Drug Delivery System Market, by End User, 2019 and 2027 (%)

Figure 34.        Hospitals and Clinics: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 35.        Home Care Settings: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (US$ Million)

Figure 36.        North America: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)

Figure 37.        North America Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (USD Million)

Figure 38.        North America: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)

Figure 39.        US: Transdermal Drug Delivery System market – Revenue and Forecast to 2027 (USD Million)

Figure 40.        Canada: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 41.        Mexico: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 42.        Europe: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019) (USD Million)

Figure 43.        Europe Transdermal Drug Delivery System Market Revenue and Forecast to 2027 (USD Million)

Figure 44.        Europe: Transdermal Drug Delivery System Market, by Country, 2019 & 2027 (%)

Figure 45.        Germany: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 46.        UK: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 47.        France: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 48.        Spain: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 49.        Italy: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 50.        Asia Pacific: Transdermal Drug Delivery Systems Market, by Key Country – Revenue (2019) (USD Million)

Figure 51.        Asia Pacific Transdermal Drug Delivery Systems Market Revenue and Forecast to 2027 (USD Million)

Figure 52.        Asia Pacific: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

Figure 53.        China: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 54.        Japan: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 55.        India: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 56.        South Korea: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 57.        Australia: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 58.        South and Central America: Transdermal Drug Delivery Systems Market, by Key Country – Revenue (2019) (USD Million)

Figure 59.        South and Central America Transdermal Drug Delivery Systems Market Revenue and Forecast to 2027 (USD Million)

Figure 60.        South and Central America: Transdermal Drug Delivery Systems Market, by Country, 2019 & 2027 (%)

Figure 61.        Brazil: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 62.        Argentina: Transdermal Drug Delivery Systems Market – Revenue and Forecast to 2027 (USD Million)

Figure 63.        Middle East & Africa: Transdermal Drug Delivery System Market, by Key Country – Revenue (2019)  (USD Million)

Figure 64.        Middle East & Africa Transdermal Drug Delivery System Market Revenue and Forecast to 2027  (USD Million)

Figure 65.        Middle East & Africa: Transdermal Drug Delivery System Market, by Country, 2018 & 2027 (%)

Figure 66.        Saudi Arabia: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        UAE: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 68.        South Africa: Transdermal Drug Delivery System Market – Revenue and Forecast to 2027 (USD Million)

Figure 69.        Impact Of COVID-19 Pandemic In North American Country Markets

Figure 70.        Impact Of COVID-19 Pandemic In Europe Country Markets

Figure 71.        Impact Of COVID-19 Pandemic In Asia-Pacific Country Markets

Figure 72.        Impact Of COVID-19 Pandemic In Rest Of World Country Markets

Figure 73.        Growth Strategies Done by the Companies in the Market, (%)

 

The List of Companies - Transdermal Drug Delivery Market

  1. Novartis Ag
  2. Johnson & Johnson Services, Inc.
  3. Glaxosmithkline Plc.
  4. Bayer Ag
  5. Mylan N.V.
  6. Boehringer Ingelheim International Gmbh
  7. Hisamitsu Pharmaceutical Co.,Inc.
  8. Luye Pharma Group
  9. Purdue Pharma LP.
  10. Lavipharm
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the transdermal drug delivery system market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global transdermal drug delivery system market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
TIPRE00002894
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Transdermal Drug Delivery System (TDDS) is described as a self-contained or discrete dosage form known as patches or semisolid forms that are applied to the intact skin. There are different types of semisolid forms, such as, creams, ointments, gels, sprays and others. Dosage forms are designed to deliver a therapeutically effective amount of drug across a patient’s skin.

The factors that are driving growth of the market are increasing prevalence of chronic diseases, growing demand for non-invasive drug delivery devices and high demand for self-administration of drugs. Moreover, strategic activities by the manufacturers are offering lucrative opportunities for the growth of the market.

The transdermal drug delivery system market majorly consists of the players such as Novartis Ag, Johnson & Johnson Services, Inc., Glaxosmithkline Plc., Bayer Ag, Mylan N.V., Boehringer Ingelheim International Gmbh, Hisamitsu Pharmaceutical Co.,Inc., Luye Pharma Group, Purdue Pharma L.P., and Lavipharm among others.

Pricing